Review of Vitamin D research identifies ethical issues in placebo use

April 5, 2018, George Washington University
Credit: CC0 Public Domain

Since World War II, medical ethics in research studies involving human subjects have shifted significantly. Despite this important growth, ethical issues remain. Nutrition supplementation research does not have guidelines around the use of placebo groups in clinical trials, posing ethical issues.

A team led by Leigh Frame, PhD, MHS, director for the Integrative Medicine Program at the George Washington University School of Medicine and Health Sciences, published a review of this issue in Nutrients, where she looked at various studies in the developing field of D research.

"We developed this review with the goal of raising awareness and starting a discussion about the potential behind study design," said Frame. "When it comes to ethics in supplementation research, we have gotten comfortable with following the standards. Our team is questioning if the standards are actually enough."

The field of vitamin D research shows variation in how placebo groups are used. The team looked at four types of control groups currently in use: active control, placebo control with restrictions on supplementation, placebo control without supplementation restrictions, and placebo control with rescue repletion therapy.

The first two control groups highlight discrete ethical issues. Active control groups can limit the ability of the study to detect a meaningful effect of the supplement. Placebo control with restrictions limits supplementation, potentially placing subjects at risk in vitamin D deficient subjects. The last two controls offer potential solutions to these ethical challenges by allowing participants access to to potentially mitigate vitamin D deficiency.

The review concludes that there is a need to establish and enforce guidelines for ethics in supplementation research for the use of placebo groups and that vitamin D research can be a leading example as the field continues to grow.

Frame and her team suggest that before using a , investigators should deeply consider the ethical implications of placebos in their study design. The authors also recommend that journals and funding agencies request thorough justifications of use, especially in cases of known nutritional deficiency or in vulnerable populations.

"It's important to note that though we focused on vitamin D research for this review, that is just one example," Frame said. "This is applicable to any supplementation study, whether it be vitamins or protein."

Explore further: Vitamin D supplementation doesn't change lean mass, BMD

More information: Leigh Frame et al, Use of Placebo in Supplementation Studies—Vitamin D Research Illustrates an Ethical Quandary, Nutrients (2018). DOI: 10.3390/nu10030347

Related Stories

Vitamin D supplementation doesn't change lean mass, BMD

April 11, 2016
(HealthDay)—For postmenopausal women with vitamin D insufficiency completing a structured weight-loss program, vitamin D3 supplementation is not associated with changes in lean mass or bone mineral density (BMD), according ...

Vitamin D supplements may benefit children with Autism Spectrum Disorder

November 21, 2016
Vitamin D supplementation improved symptoms of autism in a recent trial.

Vitamin D shows no impact on interferon response in SLE

July 10, 2015
(HealthDay)—For patients with systemic lupus erythematosus (SLE), vitamin D3 supplementation does not affect interferon (IFN) signature, according to a study published in the July issue of Arthritis & Rheumatology.

Calcium, vitamin D don't seem to reduce fracture risk in seniors

December 27, 2017
(HealthDay)—For community-dwelling older adults, supplementation with calcium, vitamin D, or both does not reduce the incidence of fractures, according to a review published in the Dec. 26 issue of the Journal of the American ...

Monthly high-dose vitamin D supplementation does not prevent cardiovascular disease

April 5, 2017
Results of a large randomized trial indicate that monthly high-dose vitamin D supplementation does not prevent cardiovascular disease, according to a study published by JAMA Cardiology.

Vitamin D doesn't impact insulin sensitivity, secretion in T2DM

May 10, 2017
(HealthDay)—For patients with type 2 diabetes (T2D) and vitamin D deficiency, vitamin D supplementation has no impact on insulin sensitivity or secretion, according to a study published online May 3 in Diabetes Care.

Recommended for you

Juul e-cigarettes pose addiction risk for young users, study finds

October 19, 2018
Teens and young adults who use Juul brand e-cigarettes are failing to recognize the product's addictive potential, despite using it more often than their peers who smoke conventional cigarettes, according to a new study by ...

Adding refined fiber to processed food could have negative health effects

October 19, 2018
Adding highly refined fiber to processed foods could have negative effects on human health, such as promoting liver cancer, according to a new study by researchers at Georgia State University and the University of Toledo.

Self-lubricating latex could boost condom use: study

October 17, 2018
A perpetually unctuous, self-lubricating latex developed by a team of scientists in Boston could boost the use of condoms, they reported Wednesday in the journal Royal Society Open Science.

How healthy will we be in 2040?

October 17, 2018
A new scientific study of forecasts and alternative scenarios for life expectancy and major causes of death in 2040 shows all countries are likely to experience at least a slight increase in lifespans. In contrast, one scenario ...

Study finds evidence of intergenerational transmission of trauma among ex-POWs from the Civil War

October 16, 2018
A trio of researchers affiliated with the National Bureau of Economic Research has found evidence that suggests men who were traumatized while POWs during the U.S. Civil War transmitted that trauma to their offspring—many ...

Father's nicotine use can cause cognitive problems in children and grandchildren

October 16, 2018
A father's exposure to nicotine may cause cognitive deficits in his children and even grandchildren, according to a study in mice publishing on October 16 in the open-access journal PLOS Biology by Pradeep Bhide of Florida ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.